Drug name - Bevyxxa

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7598276 PORTOLA PHARMS INC Pharmaceutical salts and polymorphs of a factor Xa inhibitor
Nov, 2026

(4 years from now)

CN102336702B PORTOLA PHARMS INC Xa Factor Inhibitor N - (5-Dichloro - -2 - Pyridyl)--2-[[4 - [(Dimethylamino) Iminomethyl] Benzoyl] Amino] -5 - Benzamide Of Pharmaceutical Salts And Polymorphs
Nov, 2026

(4 years from now)

CN102336702A PORTOLA PHARMS INC Xa Factor Inhibitor N-(5-Chloro--2-Pyridyl)--2-[[4-[(Dimethylamino) Methyl] Benzoyl] Amino]--5-Methoxy-Benzamide Of Pharmaceutical Salt And Polymorph
Nov, 2026

(4 years from now)

CN101304971A PORTOLA PHARMS INC Pharmaceutical Salts And Polymorphs Of A Factor Xa Inhibitor N-(5-Chloro-2- Pyridyl)-2-[[4-[(Dimethylamino)Iminomethyl]Benzoyl]Amino]-5-Methoxy-Benzamide
Nov, 2026

(4 years from now)

CN101304971B PORTOLA PHARMS INC Xa Factor Inhibitor N-(5-Chloro--2-Pyridyl)--2-[[4-[(Dimethylamino) Methyl] Benzoyl] Amino]--5-Methoxy-Benzamide Of Pharmaceutical Salt And Polymorph
Nov, 2026

(4 years from now)

IN319923B PORTOLA PHARMS INC Method Of Making A Factor Xa Inhibitor
Nov, 2026

(4 years from now)

IN201400546P2 PORTOLA PHARMS INC Method Of Making A Factor Xa Inhibitor
Nov, 2026

(4 years from now)

EP1948608B1 PORTOLA PHARMS INC Pharmaceutical Salts And Polymorphs Of N-(5-Chloro-2-Pyridinyl)-2-[[4-[(Dimethylamino)Iminomethyl]Benzoyl]Amino]-5-Methoxy-Benzamide , A Factor Xa Inhibitor
Nov, 2026

(4 years from now)

EP1948608A2 PORTOLA PHARMS INC Pharmaceutical Salts And Polymorphs Of N-(5-Chloro-2-Pyridinyl)-2-[[4-[(Dimethylamino)Iminomethyl]Benzoyl]Amino]-5-Methoxy-Benzamide , A Factor Xa Inhibitor
Nov, 2026

(4 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9555023 PORTOLA PHARMS INC Pharmaceutical salts and polymorphs of a factor Xa inhibitor Nov, 2026

(4 years from now)

US8557852 PORTOLA PHARMS INC Methods of using crystalline forms of a salt of a factor Xa inhibitor Sep, 2028

(5 years from now)

US8987463 PORTOLA PHARMS INC Methods of synthesizing factor Xa inhibitors Dec, 2030

(8 years from now)

US8404724 PORTOLA PHARMS INC Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor Mar, 2031

(8 years from now)

Drugs and Companies using BETRIXABAN ingredient

Treatment: Prophylaxis of pulmonary embolism; Prophylaxis of deep vein thrombosis (dvt); prophylaxis of venous thrombosis; Inhibiting coagulation

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
40MG CAPSULE;ORAL Discontinued
80MG CAPSULE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.